Literature DB >> 22488611

Preventive strategies in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

S Vincent Rajkumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22488611     DOI： 10.1002/ajh.23204

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

Review 1.  Smoldering multiple myeloma.

Authors:  S Vincent Rajkumar; Ola Landgren; María-Victoria Mateos
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

2.  The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice.

Authors:  T R Rosean; V S Tompkins; A K Olivier; R Sompallae; L A Norian; H C Morse; T J Waldschmidt; S Janz
Journal:  Leukemia       Date:  2014-09-03       Impact factor: 11.528

3.  Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.

Authors:  Ronald S Go; Jacob D Gundrum; Joan M Neuner
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-09-28

4.  High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma.

Authors:  Saurabh Chhabra; Sandeep Jain; Caroline Wallace; Feng Hong; Bei Liu
Journal:  J Hematol Oncol       Date:  2015-06-25       Impact factor: 17.388

5.  Early versus deferred treatment for smoldering multiple myeloma: a meta-analysis of randomized, controlled trials.

Authors:  Minjie Gao; Guang Yang; Van S Tompkins; Lu Gao; Xiaosong Wu; Yi Tao; Xiaojing Hu; Jun Hou; Ying Han; Hongwei Xu; Fenghuang Zhan; Jumei Shi
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

Review 6.  Smoldering multiple myeloma current treatment algorithms.

Authors:  S Vincent Rajkumar; Shaji Kumar; Sagar Lonial; Maria Victoria Mateos
Journal:  Blood Cancer J       Date:  2022-09-05       Impact factor: 9.812

7.  High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.

Authors:  G Bianchi; R A Kyle; D R Larson; T E Witzig; S Kumar; A Dispenzieri; W G Morice; S V Rajkumar
Journal:  Leukemia       Date:  2012-08-20       Impact factor: 11.528
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.